Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial59

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial33

Views

Views
February 20253
March 202516
April 20254
May 20250
June 20253
July 20257
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United States9
Brazil5
Spain1
Ethiopia1
 

Top cities views

Views
Cerquilho1
Chicago1
Council Bluffs1
Passo Fundo1
Paulo Afonso1
São José de Ribamar1
São José do Rio Preto1